Methods and Issues to Consider for Detection of Safety Signals From Spontaneous Reporting Databases: A Report of the DIA Bayesian Safety Signal Detection Working Group
暂无分享,去创建一个
Haoda Fu | A Lawrence Gould | Theodore C Lystig | Haijun Ma | Yun Lu | A. Gould | Haijun Ma | H. Fu | Theodore C. Lystig | Yun Lu
[1] Vincent Bauchau,et al. Optimization of a quantitative signal detection algorithm for spontaneous reports of adverse events post immunization , 2013, Pharmacoepidemiology and drug safety.
[2] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[4] M. Lindquist,et al. A Data Mining Approach for Signal Detection and Analysis , 2002, Drug safety.
[5] R. Tiwari,et al. A Likelihood Ratio Test Based Method for Signal Detection With Application to FDA’s Drug Safety Data , 2011 .
[6] E. H. Simpson,et al. The Interpretation of Interaction in Contingency Tables , 1951 .
[7] Robert Ball,et al. Effects of Stratification on Data Mining in the US Vaccine Adverse Event Reporting System (VAERS) , 2008, Drug safety.
[8] M. Lindquist,et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions , 2002, Pharmacoepidemiology and drug safety.
[9] D. J. Finney,et al. stematic Signalling of Adverse Reactions to Drugs , 1974, Methods of Information in Medicine.
[10] Brian Sauer,et al. Guidelines for good database selection and use in pharmacoepidemiology research , 2012, Pharmacoepidemiology and drug safety.
[11] D. Madigan,et al. The role of data mining in pharmacovigilance , 2005, Expert opinion on drug safety.
[12] A. Bate,et al. A Bayesian neural network method for adverse drug reaction signal generation , 1998, European Journal of Clinical Pharmacology.
[13] D Madigan,et al. Logistic Regression in Signal Detection: Another Piece Added to the Puzzle , 2013, Clinical pharmacology and therapeutics.
[14] Carol Friedman,et al. Mining multi-item drug adverse effect associations in spontaneous reporting systems , 2010, BMC Bioinformatics.
[15] Johan Hopstadius,et al. Impact of Stratification on Adverse Drug Reaction Surveillance , 2008, Drug safety.
[16] John A. Clark,et al. Spontaneous adverse event signaling methods: classification and use with health care treatment products. , 2001, Epidemiologic reviews.
[17] Gaurav Deshpande,et al. Data Mining in Drug Safety , 2010, Pharmaceutical Medicine.
[18] Ismaïl Ahmed,et al. Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting , 2009, Statistics in medicine.
[19] Andrea J Cook,et al. Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini‐Sentinel pilot , 2012, Pharmacoepidemiology and drug safety.
[20] David Madigan,et al. Large-scale regression-based pattern discovery: The example of screening the WHO global drug safety database , 2010 .
[21] Pankdeep Chhabra,et al. Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data , 2013, Drug Safety.
[22] A. Fourrier-Réglat,et al. The EU-ADR project: preliminary results and perspective. , 2009, Studies in health technology and informatics.
[23] Richard Platt,et al. The U.S. Food and Drug Administration's Mini‐Sentinel program: status and direction , 2012, Pharmacoepidemiology and drug safety.
[24] R. Altman,et al. Data-Driven Prediction of Drug Effects and Interactions , 2012, Science Translational Medicine.
[25] M. Kulldorff,et al. A conditional maximized sequential probability ratio test for Pharmacovigilance , 2010, Statistics in medicine.
[26] James G. Scott,et al. Bayes and empirical-Bayes multiplicity adjustment in the variable-selection problem , 2010, 1011.2333.
[27] A Lawrence Gould,et al. Practical pharmacovigilance analysis strategies. , 2003, Pharmacoepidemiology and drug safety.
[28] F Thiessard,et al. Pharmacovigilance Data Mining With Methods Based on False Discovery Rates: A Comparative Simulation Study , 2010, Clinical pharmacology and therapeutics.
[29] Johan Hopstadius,et al. Stratification for Spontaneous Report Databases , 2008, Drug safety.
[30] Harry Seifert,et al. Quantitative signal detection for vaccines: Effects of stratification, background and masking on GlaxoSmithKline’s spontaneous reports database , 2009, Human vaccines.
[31] Kenneth J Rothman,et al. The reporting odds ratio and its advantages over the proportional reporting ratio , 2004, Pharmacoepidemiology and drug safety.
[32] Reader Aids,et al. Estimating the Reliability , 1991 .
[33] G. D. Dal Pan,et al. The Future of Population‐Based Postmarket Drug Risk Assessment: A Regulator's Perspective , 2013, Clinical pharmacology and therapeutics.
[34] C S Lao. Application of CUSUM technique and beta-binomial model in monitoring adverse drug reactions. , 1997, Journal of biopharmaceutical statistics.
[35] Chieko Ishiguro,et al. Analysis of the Factors Influencing the Spontaneous Reporting Frequency of Drug Safety Issues Addressed in the FDA’s Drug Safety Communications, Using FAERS Data , 2014, Pharmaceutical Medicine.
[36] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[37] Edsel A. Peña,et al. POWER-ENHANCED MULTIPLE DECISION FUNCTIONS CONTROLLING FAMILY-WISE ERROR AND FALSE DISCOVERY RATES. , 2009, Annals of statistics.
[38] David Madigan,et al. Disproportionality methods for pharmacovigilance in longitudinal observational databases , 2013, Statistical methods in medical research.
[39] Yanqing Ji,et al. A Potential Causal Association Mining Algorithm for Screening Adverse Drug Reactions in Postmarketing Surveillance , 2011, IEEE Transactions on Information Technology in Biomedicine.
[40] M. Kulldorff,et al. A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance , 2011 .
[41] William DuMouchel,et al. Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System , 1999 .
[42] F Thiessard,et al. False Discovery Rate Estimation for Frequentist Pharmacovigilance Signal Detection Methods , 2010, Biometrics.
[43] A Lawrence Gould,et al. Accounting for Multiplicity in the Evaluation of “Signals” Obtained by Data Mining from Spontaneous Report Adverse Event Databases , 2007, Biometrical journal. Biometrische Zeitschrift.
[44] William DuMouchel,et al. Empirical bayes model to combine signals of adverse drug reactions , 2013, KDD.
[45] A. Bate,et al. Quantitative signal detection using spontaneous ADR reporting , 2009, Pharmacoepidemiology and drug safety.
[46] Joseph M. Tonning,et al. Perspectives on the Use of Data Mining in Pharmacovigilance , 2005, Drug safety.
[47] Patrick B. Ryan,et al. Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases , 2012, J. Biomed. Informatics.
[48] P. Rothwell,et al. External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.
[49] A. Bate,et al. Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events , 2006, Statistics in medicine.
[50] K. Sonawane,et al. Serious adverse Drug events reported to the Food and Drug Administration (FDA): analysis of the FDA adverse event reporting system (FAERS) 2006-2011 database , 2015 .
[51] S. Evans,et al. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports , 2001, Pharmacoepidemiology and drug safety.